Last reviewed · How we verify
NCT03589248
Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients
trial testing GIF score in Gastrointestinal Dysfunction in 136 participants. Completed in 1 April 2018.
1 January 2018
Quick facts
| Lead sponsor | Nanjing PLA General Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 136 |
| Start date | 1 July 2016 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 April 2018 |
Drugs / interventions tested
- GIF score
- US score
Conditions studied
- Gastrointestinal Dysfunction — all drugs for Gastrointestinal Dysfunction →
- Critical Illness — all drugs for Critical Illness →
- Intestine Ultrasonography — all drugs for Intestine Ultrasonography →
Sponsor
Nanjing PLA General Hospital
Who can join
Adults 18 to 80, any sex, with Gastrointestinal Dysfunction or Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is very important to evaluate the degree of gastrointestinal dysfunction in critical ill patients. Thus the investigators conducted transabdominal intestine ultrasonography(US) in critical ill patients to evaluated the degree of gastrointestinal dysfunction under the acute gastrointestinal injury (AGI)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Predictive value of transabdominal intestinal sonography in critically ill patients: a prospective observational study.
Gao T, Cheng MH, Xi FC, Chen Y, et al · · 2019 · cited 17× · PMID 31775838 · DOI 10.1186/s13054-019-2645-9
Verify or expand the search:
- PubMed search for NCT03589248
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal Dysfunction
Currently open trials in the same condition.
- NCT07252102 — Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients · NA · recruiting
- NCT06510348 — Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction · NA · recruiting
- NCT06740903 — Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy · Phase 2, PHASE3 · recruiting
- NCT06386471 — Personalized GI Motility Responses to Diet · NA · recruiting
- NCT05344417 — Low Pressure Pneumoperitoneum and Postoperative Ileus · NA · recruiting
Other Nanjing PLA General Hospital trials
Trials by the same sponsor.
- NCT04335474 — Surgical Versus Percutaneous Drainage in the Management of High Grade Pancreatic Trauma · unknown
- NCT04037267 — Endoscopic Intraventricular Hematoma Evacuation Surgery Versus EVD for IVH · NA · unknown
- NCT03117023 — The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer · Phase 3 · unknown
- NCT03612206 — Effect of Early Enteral Nutrition on Serum Acetylcholine Level and Inflammation in Critically Ill Patients · completed
- NCT03466684 — BIA Guided-fluid Management in Postinjury Open Abdomen · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03589248 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing PLA General Hospital
- Last refreshed: 17 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03589248.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing